171335-80-1
Chemical Structure
Exatecan
Synonym(s): DX-8951
- CAS No.: 171335-80-1
- Formula:C24H22FN3O4
- Molecular Weight:435.45
IUPAC Name: (1S,9S)-1-amino-9-ethyl-5-fluoro-9-hydroxy-4-methyl-1,2,3,9,12,15-hexahydro-10H,13H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dione
InChIKey: ZVYVPGLRVWUPMP-FYSMJZIKSA-N
SMILES: O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C5C6=C(CC[C@@H]5N)C(C)=C(F)C=C6N=C4C3=C2)=O
Biological Activity: Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
| Cat. No. | 상품명 | Purity | 제품 설명 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Exatecan | 99.96% | Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Exatecan (Standard) | 99.89% | Exatecan (Standard) is the analytical standard of Exatecan. This product is intended for research and analytical applications. Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Exatecan-d3 mesylate | Exatecan-d3 (DX8951f-d3) mesylate is deuterium-labeled Exatecan mesylate (HY-13631A). Exatecan mesylate is a DNA topoisomerase I inhibitor, with an IC50 of 0.975 μg/mL. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 1.00
HY-13631N(9R)-Exatecan -
Similarity Score 1.00
HY-13631Q(1R,9R)-rel-Exatecan -
Similarity Score 1.00
HY-13631T(1R,9S)-Exatecan -
Similarity Score 1.00
HY-13631V(1R,9R)-Exatecan -
Similarity Score 0.99
HY-13631UExatecan hydrochloride -
Similarity Score 0.93
HY-13631AExatecan mesylate -
Similarity Score 0.93
HY-13631I(1S,9R)-Exatecan mesylate -
Similarity Score 0.93
HY-13631J(1R,9R)-Exatecan mesylate -
Similarity Score 0.92
HY-178265Exatecan-3-amine -
Explore the MedChemAI to find more analogs